Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival

INTRODUCTION: Hepatitis B virus (HBV) reactivation has been reported in B-cell lymphoma patients with resolved hepatitis B (hepatitis B surface antigen [HBsAg]-negative and hepatitis B core antibody [HBcAb]-positive). This study aimed to assess HBV reactivation and hepatitis occurrence in diffuse la...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Kai-Lin, Chen, Jie, Rao, Hui-Lan, Guo, Ying, Huang, Hui-Qiang, Zhang, Liang, Shao, Jian-Yong, Lin, Tong-Yu, Jiang, Wen-Qi, Zou, De-Hui, Hu, Li-Yang, Wirian, Michael Lucas, Cai, Qing-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593350/
https://www.ncbi.nlm.nih.gov/pubmed/26058465
http://dx.doi.org/10.1186/s40880-015-0015-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593350/
https://www.ncbi.nlm.nih.gov/pubmed/26058465
http://dx.doi.org/10.1186/s40880-015-0015-9

Ejemplares similares